FTSE Mondo Visione Exchanges Index:

News Centre

News

First Products On The IBEX 35 X10 Leverage Net & IBEX 35 X10 Short Indices Listed On BME - Offering Bullish And Bearish Exposure That Is 10 Times As Much As The Daily Performance Of The IBEX 35® Net Return

Date 30/03/2015

The Spanish stock exchange today started trading on the Warrants, Certificates and other products segment the first MULTI, which offer exposure to the IBEX 35® X10 LEVERAGE NET and IBEX 35® x10 SHORT. The MULTI are exchange-traded products that track the performance of daily leverage indices as well as daily leverage short indices.
EEX New Participant Power Futures: Citigroup Global Markets Limited

Date 30/03/2015

Citigroup Global Markets Limited has been additionally admitted to exchange trading for Nordic Financial Power Futures.
MIAX Options - April 1, 2015 Fee Changes - Revisions To The Priority Customer Rebate Tiers, Market Maker Trading Permit And MEI Port Fees

Date 30/03/2015

Effective April 1, 2015, pending SEC approval, the MIAX Options Fee Schedule will be amended.
Bucharest Stock Exchange: BET-FI Index Invest Fund Will Start Trading On March 31

Date 30/03/2015

Bucharest Stock Exchange (BVB) informs that on Tuesday, March 31, 2015 start trading the fund units of the closed-end fund BET-FI Index Invest, administrated by SAI Broker. BET-FI Index Invest fund units will be traded on the fund units designed market.
First Products On The IBEX 35 X10 Leverage Net & IBEX 35 X10 Short Indices Listed On BME - Offering Bullish And Bearish Exposure That Is 10 Times As Much As The Daily Performance Of The IBEX 35® NET RETURN

Date 30/03/2015

The Spanish stock exchange today started trading on the Warrants, Certificates and other products segment the first MULTI, which offer exposure to the IBEX 35® X10 LEVERAGE NET and IBEX 35® x10 SHORT. The MULTI are exchange-traded products that track the performance of daily leverage indices as well as daily leverage short indices.

CFTC Settles Enforcement Action In District Court Against Daniel Shak For Violation Of A CFTC Administrative Order - Court Orders Shak To Pay A $100,000 Fine For Violating The CFTC’s Order

Date 30/03/2015

The U.S. Commodity Futures Trading Commission (CFTC) today announced that on March 27, 2015, Judge Emmet G. Sullivan of the U.S. District Court for the District of Columbia entered a Consent Order of permanent injunction against Defendant Daniel Shak of Las Vegas, Nevada, for his violation of a CFTC Administrative Order (CFTC Order) entered on November 25, 2013. The Court’s Consent Order requires Shak, among other things, to pay a $100,000 civil monetary penalty to settle CFTC civil charges that Shak violated the terms of the CFTC Order.
“Grading The Commission’s Record On Capital Formation: A+, D, Or Incomplete?” Speech By SEC Commissioner Daniel M. Gallagher - Vanderbilt Law School’s 17th Annual Law And Business Conference, Nashville, TN

Date 30/03/2015

Thank you, Jim [Cheek] for that kind introduction. It is an honor to be here at Vanderbilt today. Not only because Vanderbilt is such a distinguished university, but because it is home to a dear friend of mine, Craig Lewis. As Director of the SEC’s Division of Economic and Risk Analysis, Craig did more to transform the agency — in particular by crafting a new paradigm for cost-benefit analysis in the work of the Commission — than any other staffer in the Commission’s recent history. I miss having Craig at the SEC — our loss is truly Vanderbilt’s gain — but his successor Mark Flannery is doing a great job running with the baton that Craig passed to him.
Bank Of England Publishes Details Of 2015 Stress Test For Largest UK Banks And Building Societies

Date 30/03/2015

Today, the Bank of England is publishing the scenario for the 2015 stress test, which will be applied to the largest UK banks and building societies. The scenario has been agreed by the Financial Policy Committee (FPC) and Prudential Regulation Authority (PRA) Board.
Cerenis Therapeutics Lists On Euronext Paris

Date 30/03/2015

EnterNext, the Euronext subsidiary dedicated to promoting and growing the market for SMEs,today celebrated the listing of Cerenis Therapeutics, an international biopharmaceutical company dedicated to discovering and developing innovative HDL (“good cholestrol”) therapies for the treatment of cardiovascular and metabolic disease. Cerenis Therapeutics is listed on the Euronext Paris regulated market in Compartment B.
SEC Announces Fraud Charges Against Investment Adviser Accused Of Concealing Poor Performance Of Fund Assets From Investors

Date 30/03/2015

The Securities and Exchange Commission today announced fraud charges against an investment adviser and her New York-based firms accused of hiding the poor performance of loan assets in three collateralized loan obligation (CLO) funds they manage.